The Rubella (German Measles) Antibodies Panel IgG & IgM ELISA test is a blood test that measures both IgM and IgG antibodies against the rubella virus. IgM antibodies indicate a recent or acute infection, while IgG antibodies reflect past exposure or immunity, often from vaccination. This combined panel is important for diagnosing rubella, assessing immune status, and is especially critical in pregnancy to prevent congenital rubella syndrome. It helps healthcare professionals distinguish between current infection and protective immunity for effective patient management.
Yes, IgM antibodies may briefly appear after vaccination, so results should be interpreted carefully in recently vaccinated individuals.
IgG confirms immunity. Pregnant women without IgG are at risk of rubella infection, which can cause congenital rubella syndrome in the fetus.
IgM positivity strongly suggests recent infection, but doctors often confirm with clinical symptoms or repeat testing for accuracy.
Yes, IgG helps identify immune individuals, supporting public health measures during rubella outbreaks.
Yes, IgM appears early and declines within weeks, while IgG persists for years, reflecting long-term immunity.
Yes, it indicates no past exposure or immunity, meaning the person is vulnerable to rubella infection.
Rarely, false positives may occur. Doctors may confirm with additional tests if results are unclear.
Yes, it ensures they are immune, protecting vulnerable patients from rubella exposure.
Yes, they are often included in TORCH panels to assess infections affecting pregnancy and fetal health.
...
Didn't recieved OTP Yet? Resend OTP